About Zimmer Biomet Holdings (NYSE:ZMH)
Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets. The Company's product category segments include Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Medical Equipment, Supplies & Distribution
- Sub-Industry: N/A
- Symbol: NYSE:ZMH
- CUSIP: N/A
- Web: www.zimmerbiomet.com/
- 50 Day Moving Avg: $113.34
- 200 Day Moving Avg: $115.50
- 52 Week Range: $94.73 - $121.84
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 16.41
- P/E Growth: 0.00
- Net Margins: 9.42%
- Return on Equity: 7.31%
- Return on Assets: 2.76%
- Average Volume: 1.13 million shs.
Frequently Asked Questions for Zimmer Biomet Holdings (NYSE:ZMH)
What is Zimmer Biomet Holdings' stock symbol?
Zimmer Biomet Holdings trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZMH."
Who are some of Zimmer Biomet Holdings' key competitors?
Some companies that are related to Zimmer Biomet Holdings include Baxter International (BAX), Zimmer Biomet Holdings (ZBH), C.R. Bard (BCR), Align Technology (ALGN), DENTSPLY SIRONA (XRAY), Steris Plc (STE), West Pharmaceutical Services (WST), Bio-Rad Laboratories (BIO), Hill-Rom Holdings (HRC), VWR Corporation (VWR), DexCom (DXCM), Integra LifeSciences Holdings Corporation (IART), ICU Medical (ICUI), LivaNova PLC (LIVN), Neogen Corporation (NEOG), Nevro Corp. (NVRO), NuVasive (NUVA) and Haemonetics Corporation (HAE).
Who are Zimmer Biomet Holdings' key executives?
Zimmer Biomet Holdings' management team includes the folowing people:
- Daniel P. Florin, Interim Chief Executive Officer, Chief Financial Officer, Director
- Robert D. Delps, President, Americas
- Katarzyna Mazur-Hofsaess M.D. Ph.D., President, Europe, Middle East and Africa
- Sang Yi, President, Asia Pacific
- Chad F. Phipps, Senior Vice President, General Counsel, Secretary
- Larry C. Glasscock, Independent Non-Executive Chairman of the Board
- Christopher B. Begley, Independent Director
- Betsy J. Bernard, Independent Director
- Gail Koziara Boudreaux, Independent Director
- Michael Farrell, Independent Director
How do I buy Zimmer Biomet Holdings stock?
Shares of Zimmer Biomet Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Zimmer Biomet Holdings' stock price today?
MarketBeat Community Rating for Zimmer Biomet Holdings (NYSE ZMH)MarketBeat's community ratings are surveys of what our community members think about Zimmer Biomet Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Zimmer Biomet Holdings stock can currently be purchased for approximately $113.56.
Consensus Ratings for Zimmer Biomet Holdings (NYSE:ZMH) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|Consensus Price Target History for Zimmer Biomet Holdings (NYSE:ZMH)
Analysts' Ratings History for Zimmer Biomet Holdings (NYSE:ZMH)
(Data available from 10/17/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|8/10/2016||SunTrust Banks, Inc.||Initiated Coverage||Buy||N/A|
|1/7/2016||Northland Securities||Downgrade||Outperform -> Market Perform||N/A|
|12/3/2015||Royal Bank Of Canada||Reiterated Rating||Outperform||$136.00 -> $125.00||N/A|
|12/3/2015||Deutsche Bank AG||Reiterated Rating||Hold||$107.00 -> $114.00||N/A|
Earnings History for Zimmer Biomet Holdings (NYSE:ZMH)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Zimmer Biomet Holdings (NYSE:ZMH)
Current Year EPS Consensus Estimate: $6.36 EPS
Next Year EPS Consensus Estimate: $6.92 EPS
Dividend History for Zimmer Biomet Holdings (NYSE:ZMH)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Zimmer Biomet Holdings (NYSE:ZMH)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Zimmer Biomet Holdings (NYSE:ZMH)
Latest Headlines for Zimmer Biomet Holdings (NYSE:ZMH)
Zimmer Biomet Holdings (ZMH) Chart for Tuesday, October, 17, 2017